Genome Therapeutics Announces Webcast of Presentation at Tucker Anthony Sutro Life Sciences & Health Care Conference

Apr 04, 2001, 01:00 ET from Genome Therapeutics Corp.

    WALTHAM, Mass., April 4 /PRNewswire/ -- Genome Therapeutics Corp.
 (Nasdaq:   GENE) today announced that its presentation to the Tucker Anthony
 Sutro Life Sciences & Health Care Conference 2001 will be webcast live and may
 be accessed at:
 http://www.corporate-ir.net/media_files/nsd/gene/Presentations/msdw/index.htm
     Genome Therapeutics CEO and President Steven M. Rauscher will provide an
 update to investors regarding the Company's programs and strategy.  The
 presentation will be delivered at 6:00 p.m. (Eastern Time) on Thursday, April
 5, from the Ritz Carlton Hotel in Laguna Niguel California.
     Genome Therapeutics (www.genomecorp.com) is focused on the
 commercialization of genomics-based pharmaceutical, vaccine and diagnostic
 products.  The Company operates two lines of business: genomics services and
 biopharmaceutical.  The genomics services business focuses on services that
 enable other organizations to achieve their drug discovery objectives and
 includes the GTC Sequencing Center and the PathoGenome(TM) Database.  The
 biopharmaceutical business focuses on the development of novel therapeutics,
 vaccines and diagnostics to solve major medical needs and includes six
 alliances with pharmaceutical companies including Schering-Plough,
 AstraZeneca, Wyeth-Ayerst and bioMerieux, to develop genomics-based products.
 
 

SOURCE Genome Therapeutics Corp.
    WALTHAM, Mass., April 4 /PRNewswire/ -- Genome Therapeutics Corp.
 (Nasdaq:   GENE) today announced that its presentation to the Tucker Anthony
 Sutro Life Sciences & Health Care Conference 2001 will be webcast live and may
 be accessed at:
 http://www.corporate-ir.net/media_files/nsd/gene/Presentations/msdw/index.htm
     Genome Therapeutics CEO and President Steven M. Rauscher will provide an
 update to investors regarding the Company's programs and strategy.  The
 presentation will be delivered at 6:00 p.m. (Eastern Time) on Thursday, April
 5, from the Ritz Carlton Hotel in Laguna Niguel California.
     Genome Therapeutics (www.genomecorp.com) is focused on the
 commercialization of genomics-based pharmaceutical, vaccine and diagnostic
 products.  The Company operates two lines of business: genomics services and
 biopharmaceutical.  The genomics services business focuses on services that
 enable other organizations to achieve their drug discovery objectives and
 includes the GTC Sequencing Center and the PathoGenome(TM) Database.  The
 biopharmaceutical business focuses on the development of novel therapeutics,
 vaccines and diagnostics to solve major medical needs and includes six
 alliances with pharmaceutical companies including Schering-Plough,
 AstraZeneca, Wyeth-Ayerst and bioMerieux, to develop genomics-based products.
 
 SOURCE  Genome Therapeutics Corp.